Rachel Ivker MD in Springfield, Massachusetts

Medical School: New York University School Of Medicine
Graduation Year: 1991
The Primary Medical Specialty for Rachel Ivker MD is listed as: Dermatology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 33
PAC (PECOS ID)#: 6800869090
NPI #: 1821094459
NPI Created On: 06/28/2005
NPI Last Updated Listed as: 04/24/2008
Primary Taxonomy Code: 207N00000X
License Number:
205848
Listed Gender: Female

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Harvard Pilgrim Health Care Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Tangential biopsy of single skin lesion
2. Tangential biopsy of additional skin lesion
3. Punch biopsy of single skin lesion
4. Injection of up to 7 skin growths
5. Destruction of skin growth
6. Destruction of 2-14 skin growths
7. Destruction of up to 14 skin growths
8. Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs
9. Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs
10. Destruction of malignant growth (0.6 to 1.0 centimeters) of scalp, neck, hands, feet, or genitals
11. Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth
12. Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per session
13. Skin application of tar and ultraviolet b or petrolatum and ultraviolet b
14. New patient office or other outpatient visit, typically 10 minutes
15. New patient office or other outpatient visit, typically 20 minutes
16. Established patient office or other outpatient visit, typically 10 minutes
17. Established patient office or other outpatient visit, typically 15 minutes
18. Established patient office or other outpatient, visit typically 25 minutes
19. Injection, triamcinolone acetonide, not otherwise specified, 10 mg
20. Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).